Literature DB >> 2909525

The amino acid sequence of rat liver glucokinase deduced from cloned cDNA.

T L Andreone1, R L Printz, S J Pilkis, M A Magnuson, D K Granner.   

Abstract

Rat liver glucokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) was purified to homogeneity, cleaved, and subjected to amino acid sequence analysis. Forty-five percent of the protein sequence was obtained, and this information was used to design oligonucleotide probes to screen a rat liver cDNA library. A 1601-base pair cDNA (GK1) contained an open reading frame that encoded the amino acid sequences found in the peptides used to generate the oligonucleotide probes. A second cDNA was subsequently identified (GK.Z2), which is 2346 base pairs long and corresponds to nearly the entire glucokinase mRNA. Blot transfer analysis of hepatic RNA showed that glucokinase mRNA exists as a single species of about 2400 nucleotides. Four hours of insulin treatment of diabetic rats resulted in a 30-fold induction of this mRNA. GK.Z2 has a long open reading frame which, with the known partial peptide sequence, allowed us to deduce the primary structure of glucokinase. The enzyme is composed of 465 amino acids and has a mass of 51,924 daltons. Glucokinase has 53 and 33% amino acid sequence identities with the carboxyl-terminal domains of rat brain hexokinase I and yeast hexokinase, respectively. If conservative amino acid replacements are also considered, glucokinase is similar to these two enzymes at 75 and 63% of positions, respectively. The putative glucose- and ATP-binding domains of glucokinase were identified, and these regions appear to be highly conserved in the hexokinase family of enzymes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2909525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Nomenclature for mammalian glucokinase.

Authors:  P B Iynedjian; J Girard
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

2.  Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells.

Authors:  Y Kajimoto; H Watada; T a Matsuoka; H Kaneto; Y Fujitani; J Miyazaki; Y Yamasaki
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Similarity of the three-dimensional structures of actin and the ATPase fragment of a 70-kDa heat shock cognate protein.

Authors:  K M Flaherty; D B McKay; W Kabsch; K C Holmes
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Expression and site-directed mutagenesis of hepatic glucokinase.

Authors:  A J Lange; L Z Xu; F Van Poelwijk; K Lin; D K Granner; S J Pilkis
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

5.  Alternative splicing of glucokinase mRNA in rat liver.

Authors:  D J Hayzer; P B Iynedjian
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

Review 6.  Short-term regulation of glucokinase.

Authors:  E Van Schaftingen
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

7.  Transcriptional regulation of liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats.

Authors:  K Dakshinamurti; W Li
Journal:  Mol Cell Biochem       Date:  1994-03-30       Impact factor: 3.396

8.  Effects of glucose refeeding and glibenclamide treatment on glucokinase and GLUT2 gene expression in pancreatic B-cells and liver from rats.

Authors:  M Tiedge; S Lenzen
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

9.  Rat glucokinase gene: structure and regulation by insulin.

Authors:  M A Magnuson; T L Andreone; R L Printz; S Koch; D K Granner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

10.  Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.

Authors:  A Valera; J E Rodriguez-Gil; F Bosch
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.